Marissa Brittenham

CIK: 0001908044

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (40.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SGRY

Surgery Partners, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

SGRY
Surgery Partners, Inc.
Mar 13, 2026
Sale(S)
Direct
3.7K shares at avg. $12.54$46K
SGRY
Surgery Partners, Inc.
Mar 6, 2026
Sale(S)
Direct
8.8K shares at avg. $13.70$120K
SGRY
Surgery Partners, Inc.
Mar 5, 2026
Award(A)
Direct
16.4K shares at avg. $14.11$231K
SGRY
Surgery Partners, Inc.
Mar 5, 2026
Award(A)
Direct
9.2K shares at avg. $14.11$129K
SGRY
Surgery Partners, Inc.
Mar 5, 2026
Award(A)
Direct
17.7K shares at avg. $14.11$250K
SGRY
Surgery Partners, Inc.
Mar 10, 2025
Sale(S)
Direct
3.2K shares at avg. $24.09$76K
SGRY
Surgery Partners, Inc.
Mar 4, 2025
Award(A)
Direct
10.1K shares at avg. $23.80$240K
SGRY
Surgery Partners, Inc.
Mar 4, 2025
Award(A)
Direct
6.3K shares at avg. $23.80$150K
SGRY
Surgery Partners, Inc.
Feb 7, 2025
Sale(S)
Direct
14.7K shares at avg. $25.61$376K
SGRY
Surgery Partners, Inc.
Jan 31, 2025
Award(A)
Direct
25.1K shares-

		Type	Shares	Price		Ownership
Mar 13, 2026	SGRY Surgery Partners, Inc.	Sale(S)	3,657	$12.54	$45,859	Direct
Mar 6, 2026	SGRY Surgery Partners, Inc.	Sale(S)	8,785	$13.70	$120,355	Direct
Mar 5, 2026	SGRY Surgery Partners, Inc.	Award(A)	16,363	$14.11	$230,882	Direct
Mar 5, 2026	SGRY Surgery Partners, Inc.	Award(A)	9,150	$14.11	$129,107	Direct
Mar 5, 2026	SGRY Surgery Partners, Inc.	Award(A)	17,717	$14.11	$249,987	Direct
Mar 10, 2025	SGRY Surgery Partners, Inc.	Sale(S)	3,156	$24.09	$76,028	Direct
Mar 4, 2025	SGRY Surgery Partners, Inc.	Award(A)	10,084	$23.80	$239,999	Direct
Mar 4, 2025	SGRY Surgery Partners, Inc.	Award(A)	6,302	$23.80	$149,988	Direct
Feb 7, 2025	SGRY Surgery Partners, Inc.	Sale(S)	14,700	$25.61	$376,467	Direct
Jan 31, 2025	SGRY Surgery Partners, Inc.	Award(A)	25,110	-	-	Direct

1-10 of 10 transactions

About Brittenham Marissa

Brittenham Marissa (SEC CIK 0001908044) files insider reports with the SEC as Chief Strategy Officer of Surgery Partners, Inc. (SGRY).

Signal8 holds 6 ownership filings by Brittenham Marissa, all Form 4s, filed between Feb 4, 2025 and Mar 16, 2026. Those filings report 10 transactions, from Jan 31, 2025 to Mar 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Brittenham Marissa's filings is in BRENTWOOD, TN.

Recent filings by Brittenham Marissa

Mar 13, 2026: Open-market sale of SGRY shares (Form 4, code S).
Mar 6, 2026: Open-market sale of SGRY shares (Form 4, code S).
Mar 5, 2026: Grants or awards of SGRY shares (3 lines, Form 4, code A).
Mar 10, 2025: Open-market sale of SGRY shares (Form 4, code S).
Mar 4, 2025: Grants or awards of SGRY shares (2 lines, Form 4, code A).

Other insiders filing for Surgery Partners, Inc. (SGRY)

DeLuca Teresa, Director
HENDRIX BLAIR E, Director
Deane John A, Director
Forese Laura L, Director
ADLERZ CLIFFORD G, Director
Dean Lloyd H, Director

How to read Form 4 transaction codes